Hot Features
Premium
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Période:
Mode Dessin:
| Volume | 0 |
|
|||||
| Actualités | - | ||||||
| Maximum Haut | Bas Haut |
||||||
| Minimum Bas | |||||||
| Nom Action | Symbole Action | Marché | Type |
|---|---|---|---|
| Landos Biopharma Inc | LABP | NASDAQ | Action ordinaire |
| Variation Action | Variation Action% | Cours Dernier | Dernier échange
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 22,4799 | 10:00:00 |
| Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
|---|---|---|---|---|
| 22,4799 |
| Transactions Totales | Volume échangé | Volume en moyenne | Sur 52 semaines |
|---|---|---|---|
| 0 | 0 | - | 2,50 - 22,6747 |
| Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
|---|---|---|---|---|
| - | 0 | US$ 22,4799 | USD |
Bilan Comptable
| Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
|---|---|---|---|---|---|---|
| 70,06M | 3,12M | - | 0 | -21,94M | -7,04 | - |
| Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
plus d’informations financières »
Actualités Action Landos Biopharma
| Date | Heure | Source | Titre |
|---|---|---|---|
| 25/3/2024 | 13:31 | PR Newswire (US) | AbbVie to Acquire Landos Biopharma, Further Strengthening.. |
| 25/3/2024 | 13:30 | GlobeNewswire Inc. | AbbVie to Acquire Landos Biopharma, Further Strengthening.. |
| 04/3/2024 | 22:14 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 04/3/2024 | 22:06 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 14/2/2024 | 22:01 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 04/1/2024 | 14:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21/11/2023 | 14:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09/11/2023 | 14:22 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 09/11/2023 | 14:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21/9/2023 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14/9/2023 | 14:11 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09/8/2023 | 14:18 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
Forum Action Landos Biopharma
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Landos Biopharma Inc
| Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
|---|---|---|---|---|---|---|---|
| 1 semaine | 21,90 | 22,6747 | 21,90 | 22,27 | 7 758 | 0,5799 | 2,65% |
| 1 mois | 21,54 | 22,6747 | 21,43 | 21,65 | 18 626 | 0,9399 | 4,36% |
| 3 mois | 5,45 | 22,6747 | 4,83 | 17,60 | 26 271 | 17,03 | 312,48% |
| 6 mois | 3,88 | 22,6747 | 3,21 | 14,06 | 16 644 | 18,60 | 479,38% |
| 1 an | 2,847 | 22,6747 | 2,50 | 8,21 | 18 508 | 19,63 | 689,60% |
| 3 ans | 114,40 | 161,70 | 2,111 | 19,25 | 127 175 | -91,92 | -80,35% |
| 5 ans | 130,00 | 169,89 | 2,111 | 34,18 | 136 726 | -107,52 | -82,71% |
